Author

Paolo Bonfanti

University of Milano-Bicocca - Cited by 14,457 - Infectious Diseases - HIV/AIDS - Antibiotic resistance

Biography

Dr.Paolo Bonfanti, is associate professor in the Department of Infectious Diseases, L. Sacco Hospital, Milan, Italy. He is the Co-ordinator of the scientific committee of CISAI group (Italian Committee for the Study of Allergy and HIV Infection). His major research interests are: HIV/AIDS, Comorbidities in HIV infection, Antimicrobial resistance, Infectious Diseases, COVID-19, Health Economics, emerging infectious diseases, tropical diseases.
Title
Cited by
Year
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...Proceedings of the National Academy of Sciences 119 (21), 2022202
83
2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ...Human molecular genetics 31 (23), 3945-3966, 202240202
40
2022
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF …
A D’Onofrio, F Solimene, L Calò, V Calvi, M Viscusi, D Melissano, ...EP Europace 24 (2), 234-244, 2022202
28
2022
Patient-reported symptoms and sequelae 12 months after COVID-19 in hospitalized adults: a multicenter long-term follow-up study
A Comelli, G Viero, G Bettini, A Nobili, M Tettamanti, AA Galbussera, ...Frontiers in Medicine 9, 834354, 222
20
2022
Prognostic and predictive biomarkers in patients with coronavirus disease 2019 treated with tocilizumab in a randomized controlled trial
Prognostic and predictive biomarkers in patients with coronavirus disease 20 treated with tocilizumab in a randomized controlled trialJ Tom, M Bao, L Tsai, A Qamra, D Summers, M Carrasco-Triguero, ...Critical Care Medicine 50 (3), 398, 2022202
19
2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
IO Rosas, N Bräu, M Waters, RC Go, A Malhotra, BD Hunter, S Bhagani, ...EClinicalMedicine 47, 2022202
14
2022
Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19
C Carmona-Rivera, Y Zhang, K Dobbs, TE Markowitz, CL Dalgard, ...JCI insight 7 (16), 2022202
11
2022
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-1 pneumonia: a randomised controlled trial (MEDEAS)F Salton, P Confalonieri, S Centanni, M Mondoni, N Petrosillo, P Bonfanti, ...European Respiratory Journal 61 (4), 2023202
9
2023
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
A Comelli, C Genovese, A Lombardi, C Bobbio, L Scudeller, U Restelli, ...Antimicrobial Resistance & Infection Control 11 (1), 108, 2022202
5
2022
Reply to: Hultström et al., genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. mannose-binding lectin …
R Asselta, EM Paraboschi, M Stravalaci, P Invernizzi, P Bonfanti, A Biondi, ...Nature Immunology 23 (6), 86-867, 2022202
5
2022
Clonal hematopoiesis is not significantly associated with Covid-19 disease severity
Y Zhou, R Shalhoub, SN Rogers, S Yu, M Gu, MA Fabre, PM Quiros, ...Blood, The Journal of the American Society of Hematology 140 (14), 160-16, 2022202
5
2022
Assessing the mortality risk in older patients hospitalized with a diagnosis of sepsis: the role of frailty and acute organ dysfunction
E Patrizio, A Zambon, P Mazzola, F Massariello, M Galeazzi, ...Aging Clinical and Experimental Research 3 (10), 2335-233, 2022202
4
2022
Incident atrial fibrillation and in-hospital mortality in SARS-CoV-2 patients
A Maloberti, C Giannattasio, P Rebora, G Occhino, N Ughi, M Biolcati, ...Biomedicines 10 (8), 190, 2022202
4
2022
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19
G Lapadula, R Leone, DP Bernasconi, A Biondi, E Rossi, M D’Angiò, ...Frontiers in Immunology 13, 933960, 2022202
4
2022
Reversibility of central nervous system adverse events in course of ART
L Taramasso, G Orofino, E Ricci, B Menzaghi, GV De Socio, N Squillace, ...Viruses 1 (5), 1028, 2022202
4
2022
Neurovascular and infectious disease phenotype of acute stroke patients with and without COVID-19
S Beretta, F Iannuzzi, S Diamanti, E Bianchi, L D’Urbano, C Elisa, ...Neurological Sciences 4 (8), 4619-4625, 2022202
3
2022
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
L Aurisicchio, N Brambilla, ME Cazzaniga, P Bonfanti, S Milleri, ...Molecular Therapy 1 (), 788-800, 20220
3
2023
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study
L Valenti, S Pelusi, A Aghemo, S Gritti, L Pasulo, C Bianco, C Iegri, ...Hepatology Communications 6 (4), 867-877, 2022202
3
2022
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19?
MC Ferrara, C Zarcone, E Tassistro, P Rebora, E Rossi, F Luppi, G Foti, ...Aging Clinical and Experimental Research 35 (), 455-461, 030
2
2023
Immunotyper-sr: A novel computational approach for genotyping immunoglobulin heavy chain variable genes using short read data
M Ford, A Hari, O Rodriguez, J Xu, J Lack, C Oguz, Y Zhang, S Weber, ...International conference on research in computational molecular biology, 38-384, 0
2
2022

Referred From: https://scholar.google.com/citations?user=WJE4ylgAAAAJ&hl=it

Cited by
Citations 14457
h-index 49
i10-index 141
Recommended Journals
Open Access Journals